Emcure Pharmaceuticals IPO to Open on July 3, 2024

Initial Public Offering (IPO) Details

Subscription Period:

July 3, 2024

Issue Size:

Rs 1,952 crore

Price Band:

Not yet announced

Key Highlights

Emcure Pharmaceuticals, a generic drug manufacturer, is set to launch its IPO on July 3, 2024. The company's revenue increased by 11.33% in the financial year ending with March, while its profit after tax (PAT) declined by 61%.

The IPO funds will be used for capital expenditure, working capital requirements, and repayment of debt.

Financial details for Emcure UK, Zuventus Healthcare Limited, and Marcan are also available in the provided links.